PSP investing in U.K. real estate; Caisse in medical startup fund, Indian infrastructure
The agreement marks the second time the two organizations have teamed up on a real estate investment. In 2015, they invested in a portfolio of commercial properties in central London, currently valued at more than £400 million.
As part of the new investment, the pair will acquire a mix of ground-up and standing assets located in the CB1 Estate in Cambridge.
“Building on our existing partnership with Aviva, PSP is continuing its strategy of investing in key innovation markets,” said Stéphane Jalbert, managing director for Europe and Asia Pacific in real estate investments at the PSP, in a press release. “Cambridge is one of the U.K.’s leading knowledge clusters for artificial intelligence and life sciences, and we believe the regeneration of the Station Road area will outperform in the long term.”
Amplitude has now obtained more than 50 per cent of its financing target for its fresh $200-million fund, with the Caisse, BDC Capital, Fonds de solidarité FTQ, Teralys and Investissement Québec all participating so far.
“This investment aligns with our commitment to support companies operating in life sciences, which is a growing sector of our innovation economy,” said Charles Émond, executive vice-president and head of Quebec investments and global strategic planning at the Caisse, in a press release. “With the progress in recent years on data analysis and new technology integration, new medical treatments are developing at a rapid pace. Amplitude is well positioned to benefit from this transformation and support the companies that will stand out.”